These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1764821)
1. Role of lipoprotein peroxidation in the pathogenesis of atherosclerosis. Steinbrecher UP Clin Cardiol; 1991 Nov; 14(11):865-7. PubMed ID: 1764821 [TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and its role in atherosclerosis. Esterbauer H; Wäg G; Puhl H Br Med Bull; 1993 Jul; 49(3):566-76. PubMed ID: 8221023 [TBL] [Abstract][Full Text] [Related]
3. [Oxidized lipoproteins and atherogenesis]. Jürgens G; Chen Q; Ledinski G; Kager G; Hammer A; Esterbauer H Acta Med Austriaca; 1993; 20(4):85-9. PubMed ID: 8237282 [TBL] [Abstract][Full Text] [Related]
4. Role of oxidative modifications in atherosclerosis. Stocker R; Keaney JF Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [TBL] [Abstract][Full Text] [Related]
5. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ylä-Herttuala S Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825 [TBL] [Abstract][Full Text] [Related]
6. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis. Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Arai H; Kawai C Eur Heart J; 1990 Aug; 11 Suppl E():122-7. PubMed ID: 2226520 [TBL] [Abstract][Full Text] [Related]
8. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235 [TBL] [Abstract][Full Text] [Related]
9. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Aviram M Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155 [TBL] [Abstract][Full Text] [Related]
10. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk]. Yoshida H Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275 [TBL] [Abstract][Full Text] [Related]
11. Modified forms of low density lipoprotein and atherosclerosis. Aviram M Atherosclerosis; 1993 Jan; 98(1):1-9. PubMed ID: 8457244 [TBL] [Abstract][Full Text] [Related]
14. The role of oxidized low density lipoprotein in atherogenesis. Jialal I; Devaraj S J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of the atherogenic process. Schwartz CJ; Kelley JL; Nerem RM; Sprague EA; Rozek MM; Valente AJ; Edwards EH; Prasad AR; Kerbacher JJ; Logan SA Am J Cardiol; 1989 Oct; 64(13):23G-30G. PubMed ID: 2679027 [TBL] [Abstract][Full Text] [Related]
17. The oxidative modification hypothesis of atherogenesis: an overview. Chisolm GM; Steinberg D Free Radic Biol Med; 2000 Jun; 28(12):1815-26. PubMed ID: 10946223 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Janero DR Free Radic Biol Med; 1991; 11(1):129-44. PubMed ID: 1937126 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of atherosclerosis. Chobanian AV Am J Cardiol; 1992 Nov; 70(17):3G-7G. PubMed ID: 1449096 [TBL] [Abstract][Full Text] [Related]
20. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Aliev G; Burnstock G Histol Histopathol; 1998 Jul; 13(3):797-817. PubMed ID: 9690137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]